Avid Bioservices Inc (CDMO)

[biopharm]

Interesting comments by Rahul re: Big Pharma Mafia and José Baselga now invited onto BODs over at Bristol Myers Squibb

PS Targeting ....

The value of Biomarkers

The new BODs scheme was required for a transfer of IP to Oncologie

4. Rahul Jasuja - Noble Life Science Partners noblelsp.com/research
RJ: ”Thanks for taking my question and glad to know that PS is now being recognized by big pharma and the immunology mafia so to say. So couple of questions pertaining to how PS with checkpoint inhibitors is differentiated from the conventional checkpoints inhibitors, like the CTLA-4, PD-1, PD-L1 pathways. From the data that's been represented at ImVacS, and also in discussions they’ve had with you guys, besides blocking just PS binding to its receptors on immune cells, there is an FC- FC gamma -based effector function leading to ADCC and so on and so forth - an immune effector function that other checkpoint inhibitors do not have blocking PD-1 or blocking CTLA-4. So, you’ve got a component here that is beyond other checkpoint inhibitors, that brings in an effector function that others do not have. Looking at that aspect or looking at some of the translational data, do you think that beyond the PD-1, PD-L1 non-immunogenic tumors, there is a possibility that PS blockade will have far more effect potentially driving [ph??] antigen presentation. Any comments on that?” ..
...

Jose is not invited to BMS BOD for NO reason at all